Home / Companies / Results / Ipca Labs Q1 profit jumps more than 3-folds to Rs 445.68 cr on robust sales

Ipca Labs Q1 profit jumps more than 3-folds to Rs 445.68 cr on robust sales

The company had posted a net profit of Rs 129.43 crore for the corresponding period of the previous fiscal, Ipca Labs said in a BSE filing

Premium

Shares of Ipca Laboratories closed at Rs2,099.60per unit on BSE, up 7.36 per cent over previous close.

1 min read Last Updated : Aug 10 2020 | 7:36 PM IST

Drug firm Ipca Laboratories on Monday reported over three-fold jump in its consolidated net profit to Rs 445.68 crore for the quarter ended June due to robust sales.

The company had posted a net profit of Rs 129.43 crore for the corresponding period of the previous fiscal, Ipca Labs said in a BSE filing.

Consolidated total income stood at Rs 1,546.49 crore for the quarter under consideration. It was Rs 1,098.53 crore in the same period year ago, it added.

Shares of Ipca Laboratories closed at Rs 2,099.60per unit on BSE, up 7.36 per cent over previous close.

Topics : IPCA Laboratories Q1 results Pharma Companies

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in